dninauki.ksma@yahoo.com 92, Akhunbaev street, 720020, Bishkek 0312 54-94-60 рус кыр

Abstract Requirements

Home For participants Abstract Requirements

REQUIREMENTS FOR ABSTRACT SUBMISSION

Abstracts must be submitted in DOC or DOCX format.

Font: Times New Roman, size 12, single spacing.

Maximum length: 1.0 page, margins: top and bottom — 2 cm, left — 3 cm, right — 1 cm.

At the top: TITLE OF THE ABSTRACT (bold, all caps).

Author names: Full surname and initials (bold, underline the presenter’s surname). If there are multiple authors from different institutions, superscript numbers (1, 2, etc.) should follow the initials, corresponding to their respective affiliations listed below. If all authors are from the same institution, no superscripts are used.

Next line: Name of the institution(s).

The structure of the abstract should include the following sections:
Relevance, Objective, Materials and Methods, Results, Conclusions, and Recommendations.

References: A list of references should be included. It is recommended to cite a reasonable number of references (3 to 5). In-text references should be indicated in square brackets, e.g., [1,3-5]. References should be formatted according to the Vancouver style.

Example of Abstract Formatting

ON BREAST CANCER INCIDENCE IN AKMOLA REGION

Baurzhankyzy N.1, Telmanova Zh.B.2, Zhigitay D.R.3, Igisin N.S.4,1,2,5

1. Higher School of Medicine, Sh. Ualikhanov Kokshetau University, Kokshetau, Kazakhstan

2. Central Asian Institute for Medical Research, Astana, Kazakhstan

3. Kokshetau Higher Medical College, Kokshetau, Kazakhstan

4. Research Institute of Life and Health Sciences, Sh. Ualikhanov Kokshetau University, Kokshetau, Kazakhstan

5. Asian Pacific Organization for Cancer Prevention, Bishkek, Kyrgyzstan

Relevance. Breast cancer (BC) ranks first in the global cancer incidence structure, with over 2.3 million new cases registered annually [1]. It has been established that more than 81.5% of BC cases occur in countries with high or very high human development indices [2]. This study aims to assess the incidence of BC in the Akmola region of Kazakhstan.

Objective. To analyze the dynamics of breast cancer incidence in the Akmola region to assess trends and develop preventive measures.

Materials and Methods. This retrospective study was based on reporting data from the Ministry of Health of the Republic of Kazakhstan (Form 7, Form 35) for the period from 2009 to 2018 regarding new BC cases in the region. Descriptive and analytical methods of medical statistics were used [3], and calculations included average annual values (M), standard error (m), 95% confidence interval (95% CI), and annual growth/decline rates (%).

Results. During the study period, 1,977 new cases of BC were registered, accounting for 4.9% of all cases registered nationwide (40,199). The highest proportion of cases was observed in the 50-59 age group—665 cases, comprising 33.6% of the total. The average age of BC patients in the region was 58.5±0.4 years (95% CI=57.7–59.2). The study period showed an increase in the average age of patients from 57.3±0.9 years in 2009 to 60.3±0.7 years in 2018, with an average annual growth rate of +0.4%. The crude incidence rate also demonstrated an increase from 44.4±3.40/0000 in 2009 to 60.2±4.00/0000 in 2018, with an annual growth rate of +4.0%. The average crude incidence rate for BC among women in the Akmola region was 51.9±2.600/0000 (95% CI=46.8–57.1), reflecting the overall incidence level in the region. Age-specific incidence rates showed a unimodal increase with a peak in the 60–69 age group at 149.4±10.20/0000 (95% CI=129.5–169.4). Trends in age-specific BC incidence rates tended to increase in nearly all age groups except those under 30 years old (growth rate −12.6%).

Conclusions and Recommendations. Analysis of BC data among residents of the Akmola region revealed that overall incidence trends and age-specific trends showed an upward trajectory. The results of this study are recommended for use in monitoring and evaluating cancer control measures, particularly in assessing preventive actions and risk factors.

References

  1. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available at: https://gco.iarc.who.int/today.
  2. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). The Lancet Oncology. 2008;9(8):730-756. DOI: 10.1016/S1470-2045(08)70179-7.
  3. Petri A., Sabin K. Illustrative Medical Statistics. Educational manual. Translated into Russian, edited by V.P. Leonov. GEOTAR-Media, 2021. 232 p.